All In MedTech

FDA Clearance Tracker · P030036-S139

Medtronic SelectSecure™ MRI SureScan™ Lead

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 3, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 3, 2022

Approved

Time to decision

73 days

Received Jul 22, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P030036-S139
Device name
Medtronic SelectSecure™ MRI SureScan™ Lead
Applicant location
Mounds View, MN
Received
Jul 22, 2022
Decided
Oct 3, 2022
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P030036

Device type

Device class
Class III

Every decision under product code NVN

FDA's approval statement

As written in FDA's record.

Approval to expand the indications for use for the Medtronic SelectSecure MRI SureScan Lead Model 3830 to include pacing at the left bundle branch area as an alternative to right ventricular pacing.

Source documents

Other decisions for Medtronic Cardiac Rhythm Disease Management

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.